UBS Group’s Quantum Biopharma Ltd. Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $929K | Buy |
45,883
+44,269
| +2,743% | +$896K | ﹤0.01% | 4405 |
|
2025
Q1 | $12.4K | Buy |
+1,614
| New | +$12.4K | ﹤0.01% | 7185 |
|
2024
Q3 | – | Sell |
-478
| Closed | -$5.03K | – | 8897 |
|
2024
Q2 | $5.03K | Sell |
478
-89
| -16% | -$937 | ﹤0.01% | 6873 |
|
2024
Q1 | $26.4K | Buy |
567
+161
| +40% | +$7.49K | ﹤0.01% | 5623 |
|
2023
Q4 | $24.3K | Buy |
+406
| New | +$24.3K | ﹤0.01% | 5779 |
|
2021
Q4 | – | Sell |
-14
| Closed | -$1K | – | 9474 |
|
2021
Q3 | $1K | Buy |
14
+6
| +75% | +$429 | ﹤0.01% | 8112 |
|
2021
Q2 | $1K | Sell |
8
-9
| -53% | -$1.13K | ﹤0.01% | 8088 |
|
2021
Q1 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 7613 |
|
2020
Q4 | – | Sell |
-75
| Closed | -$12K | – | 7689 |
|
2020
Q3 | $12K | Buy |
75
+28
| +60% | +$4.48K | ﹤0.01% | 5840 |
|
2020
Q2 | $12K | Buy |
+47
| New | +$12K | ﹤0.01% | 6051 |
|